Edesa Biotech Inc (NQ: EDSA )
1.035
-0.035
(-3.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2023
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 42,598 |
| Open | 1.040 |
| Bid (Size) | 1.030 (10) |
| Ask (Size) | 1.050 (3) |
| Prev. Close | 1.070 |
| Today's Range | 1.020 - 1.080 |
| 52wk Range | 0.7600 - 3.200 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
February 10, 2023
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
February 01, 2023
Edesa Biotech's Dermatitis Study Data Fails To Cheer Investors
January 17, 2023
Nasdaq Edges Higher; Neovasc Shares Jump
January 17, 2023
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
January 17, 2023
Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations
January 17, 2023
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
January 17, 2023
FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate
December 20, 2022
Edesa Biotech Reports Fiscal Year 2022 Results
December 16, 2022
What Is Going on With Edesa Biotech (EDSA) Stock Today?
September 30, 2022
Edesa Biotech to Present at Upcoming H.C. Wainwright Investor Conference
September 08, 2022
Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment
September 07, 2022
Edesa Biotech Reports Fiscal 3rd Quarter 2022 Results
August 12, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.